CD19 and precursor B-cell acute lymphoblastic leukemia: Below, we describe the currently known tumor-intrinsic mechanisms of CD19 CAR-T therapy resistance, highlighting the similarities and differences between various B cell malignancies, particularly B-ALL and B cell lymphomas (Figure 1).